fluconazole has been researched along with Inflammation in 15 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Inflammation: A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we report a case of a patient affected by extended cutaneous candidiasis diagnosed by culture examination; a JHR occurred after an accidental overdose of oral fluconazole." | 7.96 | A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole. ( Magri, F; Muscianese, M; Pranteda, G, 2020) |
| "Rats in Fp groups were given fluconazole in doses of 0 mg/kg, 3 mg/kg, 10 mg/kg, and 30 mg/kg by gavage 30 min before induction of peritonitis." | 7.72 | Fluconazole attenuates lung injury and mortality in a rat peritonitis model. ( Arshaduddin, M; Evans, DP; Jacobs, S; Khan, HA; Moutaery, AA; Tariq, M, 2003) |
| " Here, we report a case of a patient affected by extended cutaneous candidiasis diagnosed by culture examination; a JHR occurred after an accidental overdose of oral fluconazole." | 3.96 | A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole. ( Magri, F; Muscianese, M; Pranteda, G, 2020) |
| "Rats in Fp groups were given fluconazole in doses of 0 mg/kg, 3 mg/kg, 10 mg/kg, and 30 mg/kg by gavage 30 min before induction of peritonitis." | 3.72 | Fluconazole attenuates lung injury and mortality in a rat peritonitis model. ( Arshaduddin, M; Evans, DP; Jacobs, S; Khan, HA; Moutaery, AA; Tariq, M, 2003) |
| "Osteomyelitis is a bone inflammation that can be related to various infectious agents." | 3.01 | Cryptococcus neoformans osteomyelitis of the tibia: a case report and review of the literature. ( Ampadiotaki, MM; Diamantopoulou, K; Georgousi, K; Gourtzelidis, G; Kokkinis, C; Lelekis, M; Pallis, D; Papadakis, SA; Tatakis, F; Tsivelekas, K, 2023) |
| "Fluconazole treatment in utero decreased intestinal C." | 1.43 | Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine. ( Hornef, MW; Jacobs, EM; Janssen, LE; Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Newnham, JP; Nikiforou, M; Payne, MS; Saito, M; Wolfs, TG, 2016) |
| "Fluconazole treatment temporarily decreased the pulmonary and chorioamnion inflammatory responses." | 1.42 | Fluconazole treatment of intrauterine Candida albicans infection in fetal sheep. ( Jobe, AH; Kallapur, SG; Kemp, MW; Kramer, BW; Maneenil, G; Miura, Y; Newnham, JP; Payne, MS; Senthamarai Kannan, P, 2015) |
| "Treatment with Fluconazole for a period of four weeks successfully cured the infection." | 1.34 | Exacerbated inflammatory reaction to Trichophyton rubrum infection on an HIV-positive patient successfully treated with fluconazole. ( de Oliveira Teixeira, F; Mendoza, L; Vilela, L; Vilela, R, 2007) |
| "Fluconazole was labelled with (99m)Tc and radiochemical analysis showed less than 5% impurities." | 1.31 | Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections. ( Lupetti, A; Mazzi, U; Nibbering, PH; Pauwels, EK; Welling, MM, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saunders, MJ | 1 |
| Edwards, BS | 1 |
| Zhu, J | 1 |
| Sklar, LA | 1 |
| Graves, SW | 1 |
| Samukawa, S | 3 |
| Yoshimi, R | 3 |
| Kojitani, N | 3 |
| Uzawa, Y | 3 |
| Takase-Minegishi, K | 3 |
| Kirino, Y | 3 |
| Soejima, Y | 3 |
| Kato, H | 3 |
| Nakajima, H | 3 |
| Papadakis, SA | 1 |
| Gourtzelidis, G | 1 |
| Pallis, D | 1 |
| Ampadiotaki, MM | 1 |
| Tatakis, F | 1 |
| Tsivelekas, K | 1 |
| Georgousi, K | 1 |
| Kokkinis, C | 1 |
| Diamantopoulou, K | 1 |
| Lelekis, M | 1 |
| Muscianese, M | 1 |
| Magri, F | 1 |
| Pranteda, G | 2 |
| Morais, EA | 1 |
| Martins, EM | 1 |
| Boelone, JN | 1 |
| Gomes, DA | 1 |
| Goes, AM | 1 |
| Maneenil, G | 1 |
| Payne, MS | 2 |
| Senthamarai Kannan, P | 1 |
| Kallapur, SG | 2 |
| Kramer, BW | 2 |
| Newnham, JP | 2 |
| Miura, Y | 1 |
| Jobe, AH | 2 |
| Kemp, MW | 2 |
| Qiu, X | 1 |
| Zhang, F | 1 |
| Yang, X | 1 |
| Wu, N | 1 |
| Jiang, W | 1 |
| Li, X | 2 |
| Liu, Y | 1 |
| Schaller, M | 1 |
| Friedrich, M | 1 |
| Papini, M | 1 |
| Pujol, RM | 1 |
| Veraldi, S | 1 |
| Nikiforou, M | 1 |
| Jacobs, EM | 1 |
| Hornef, MW | 1 |
| Saito, M | 1 |
| Janssen, LE | 1 |
| Wolfs, TG | 1 |
| Tariq, M | 1 |
| Moutaery, AA | 1 |
| Arshaduddin, M | 1 |
| Khan, HA | 1 |
| Evans, DP | 1 |
| Jacobs, S | 1 |
| Vilela, R | 1 |
| de Oliveira Teixeira, F | 1 |
| Vilela, L | 1 |
| Mendoza, L | 1 |
| Jafari, HS | 1 |
| Sáez-Llorens, X | 1 |
| Severien, C | 1 |
| Parras, F | 1 |
| Friedland, I | 1 |
| Rinderknecht, S | 1 |
| Ehrett, S | 1 |
| Olsen, KD | 1 |
| Abramowsky, C | 1 |
| McCracken, GH | 1 |
| Matsuyama, W | 1 |
| Takenaga, S | 1 |
| Nakahara, K | 1 |
| Kawabata, M | 1 |
| Iwakiri, Y | 1 |
| Arimura, K | 1 |
| Osame, M | 1 |
| Bornstein, J | 1 |
| Livnat, G | 1 |
| Stolar, Z | 1 |
| Abramovici, H | 1 |
| Lupetti, A | 1 |
| Welling, MM | 1 |
| Mazzi, U | 1 |
| Nibbering, PH | 1 |
| Pauwels, EK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Vestibulitis Educational Seminar Trial Study"[NCT00278850] | 500 participants (Actual) | Observational | 2006-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for fluconazole and Inflammation
| Article | Year |
|---|---|
Cryptococcus neoformans osteomyelitis of the tibia: a case report and review of the literature.
Topics: Cryptococcosis; Cryptococcus neoformans; Female; Fluconazole; Humans; Inflammation; Osteomyelitis; T | 2023 |
Topical antifungal-corticosteroid combination therapy for the treatment of superficial mycoses: conclusions of an expert panel meeting.
Topics: Administration, Topical; Adrenal Cortex Hormones; Antifungal Agents; Dermatomycoses; Drug Therapy, C | 2016 |
1 trial available for fluconazole and Inflammation
| Article | Year |
|---|---|
Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Inflammation; Vulvar Dise | 2000 |
12 other studies available for fluconazole and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Pr | 2010 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Anti-Retroviral Ag | 2023 |
A case of Jarisch-Herxheimer reaction in candidiasis treated with systemic fluconazole.
Topics: Anti-Bacterial Agents; Candidiasis; Fluconazole; Humans; Inflammation; Syphilis | 2020 |
Immunization with recombinant Pb27 protein reduces the levels of pulmonary fibrosis caused by the inflammatory response against Paracoccidioides brasiliensis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Caspase 3; Collagen; Fluconazole; Fungal Proteins; Fun | 2015 |
Fluconazole treatment of intrauterine Candida albicans infection in fetal sheep.
Topics: Analysis of Variance; Animals; Antifungal Agents; Candidiasis; Female; Fetal Diseases; Fluconazole; | 2015 |
Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis.
Topics: Acute Disease; Animals; beta-Glucans; Colitis; Colon; Cytokines; Dextran Sulfate; Discriminant Analy | 2015 |
Intra-amniotic Candida albicans infection induces mucosal injury and inflammation in the ovine fetal intestine.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Chorioamnionitis; Cytokines; Female; Fetu | 2016 |
Fluconazole attenuates lung injury and mortality in a rat peritonitis model.
Topics: Adjuvants, Immunologic; Animals; Ascitic Fluid; Disease Models, Animal; Dose-Response Relationship, | 2003 |
Exacerbated inflammatory reaction to Trichophyton rubrum infection on an HIV-positive patient successfully treated with fluconazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Female; Fluconazole; HIV Infections | 2007 |
Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain; Candida albicans; Candidiasis; Cytokines; Flucona | 1994 |
Idiopathic hypoparathyroidism with fungal seminal vesiculitis.
Topics: Adult; Antifungal Agents; Fluconazole; Genital Diseases, Male; Humans; Hypoparathyroidism; Inflammat | 1997 |
Technetium-99m labelled fluconazole and antimicrobial peptides for imaging of Candida albicans and Aspergillus fumigatus infections.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Candidiasis; Diagnosis, Differential; Fluconazole; Hu | 2002 |